Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Discover how SciY empowers scientists

In this interview, NewsMedical talks to Santi Dominguez about the genesis of SCiY, and how the consortium intends to empower scientists and researchers.

From SciY 31 May 2024

H.E.L Group extends sales and support with appointment of specialist distributors

H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, today announced the extension of its global sales network with the appointment of two distributors: Paralab and ProAnalytics.

From H.E.L Group 31 May 2024

The chicken and egg problem of fighting another flu pandemic

Even a peep of news about a new flu pandemic is enough to set scientists clucking about eggs.

31 May 2024

Could edible robots be the future of food and medicine?

A review in Nature Reviews Materials explores the potential of edible materials in creating robotic foods and edible robots, highlighting their therapeutic and environmental benefits, while addressing current research challenges.

29 May 2024

New type of immunotherapy shows promising preclinical results against osteosarcoma

A new type of immunotherapy, developed by UCL researchers, has shown promising preclinical results against a bone cancer called osteosarcoma, as part of a study in mice.

29 May 2024

Microplastics: Invisible to the eye but severely harmful to pregnancy and metabolic outcomes

The effects of polystyrene microplastics on pregnancy outcomes and glucose metabolism.

29 May 2024

Cellular Origins and Cell and Gene Therapy Catapult collaborate to demonstrate universal automation of CGT manufacturing

Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and the Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specializing in the advancement of the cell and gene therapy industry, today announced a collaboration to demonstrate universal automation of CGT manufacturing.

29 May 2024

Reducing cancer treatment frequency could cut greenhouse gas emissions

Changing how often a popular cancer therapy is delivered would reduce greenhouse gas emissions and improve environmental impact without decreasing cancer survival, according to a new analysis from researchers at the University of Michigan Health Rogel Cancer Center.

28 May 2024

Assessing the effects of COVID-19 on breast cancer screening rates

Breast cancer is the second most common cancer among women in the U.S. Early detection of the disease through screening can greatly improve the chances of successful treatment and is an essential preventive service in primary care.

28 May 2024

Changing the landscape of R&D to build clinical success from the ground up

In this interview, NewsMedical talks to Amanda Jones at Revvity about the strategies and solutions available to revolutionize the landscape of R&D in clinical research.

From Revvity 28 May 2024

$Osaka University to pioneer world-first clinical trial for refractory prostate cancer with alpha-ray therapy$

Osaka University to pioneer world-first clinical trial for refractory prostate cancer with alpha-ray therapy

A research team at Osaka University will start an investigator-initiated clinical trial for refractory prostate cancer patients after the successful development of a new alpha-ray therapeutic agent ([At-211] PSMA-5) and confirmation of its efficacy in animal models.

27 May 2024

California pays meth users to get sober

Here in the rugged foothills of California's Sierra Nevada, the streets aren't littered with needles and dealers aren't hustling drugs on the corner.

22 May 2024

UEA researchers develop novel resin for 3D printing intraocular devices

University of East Anglia researchers have made a significant breakthrough in ocular device technology with the introduction of a novel resin for 3D printing intraocular devices.

20 May 2024

Novel gene-delivery vehicle shows promise for treating brain disorders

In an important step toward more effective gene therapies for brain diseases, researchers from the Broad Institute of MIT and Harvard have engineered a gene-delivery vehicle that uses a human protein to efficiently cross the blood-brain barrier and deliver a disease-relevant gene to the brain in mice expressing the human protein.

16 May 2024

3D printing technique enables the fabrication of customized pharmaceutical tablets

A new technique for 3D printing medication has enabled the printing of multiple drugs in a single tablet, paving the way for personalized pills that can deliver timed doses.

15 May 2024

Enhanced Semiconductor System Refurbishment: The Monmouth Scientific Modular Cleanroom at NIKON Precision's Scottish Facility

NIKON Precision sought to enhance its semi-conductor machinery refurbishment process by incorporating an advanced cleanroom facility into its existing structure in Scotland.

From Monmouth Scientific 14 May 2024

ArgusEye closes €2.8 million funding to accelerate bioprocessing

ArgusEye, a provider of innovative sensor solutions for real-time monitoring of biological systems, today announced the close of its funding, raising €2.8 million EUR (~£2.4 million GBP) bringing the total raised by the Company to €3.45 million EUR (~£3 million GPB).

From ArgusEye AB 13 May 2024

Early feasibility studies on climate-friendly albuterol inhaler completed

DevPro Biopharma and Bespak have announced the completion of early feasibility studies on DP007, a new formulation of albuterol in a pressurized metered dose inhaler (pMDI) which shows comparable performance to Ventolin® HFA but with a significant reduction in greenhouse gas emissions.

11 May 2024

New collaboration to combat river blindness and lymphatic filariasis

Prof. Achim Hoerauf, Director of the Institute of Medical Microbiology, Immunology and Parasitology at the University Hospital Bonn (UKB), and his team have succeeded in collaborating with the Department of Pharmaceutical Technology and Biopharmacy at the University of Bonn and the Helmholtz Center for Infection Research (HZI), to enter into a partnership with the Japanese pharmaceutical company Eisai for the further development of the antibiotic corallopyronin A (CorA) as a treatment for the neglected tropical diseases river blindness and lymphatic filariasis and to raise a large amount of funding.

10 May 2024